1980
DOI: 10.1021/bi00546a010
|View full text |Cite
|
Sign up to set email alerts
|

Independent activation of the acetylcholine receptor from Torpedo californica at two sites

Abstract: Membrane vesicles enriched in acetylcholine receptor were prepared from the electroplax tissue of Torpedo californica. The receptor was reduced with dithiothreitol to expose a sulfhydryl group near the ligand binidng site and then treated in one of the following ways: (1) affinity alkylated treated in one of the following ways: (1) affinity alkylated with bromoacetylcholine, a receptor activator, (2) affinity alkylated with maleimidobenzyltrimethylammonium, a receptor inhibitor, or (3) reoxidized to the native… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
29
0

Year Published

1981
1981
2001
2001

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 46 publications
(34 citation statements)
references
References 16 publications
5
29
0
Order By: Relevance
“…They differ by their kinetics of binding and dissociation of a bungarotoxin (Weber & Changeux 1974a, b, c;Maelicke & Reich, 1976;Maelicke et al, 1977;Kang & Maelicke, 1980;Maelicke et al, 1989), by their affinities for the competitive antagonists d-tubocurarine (Neubig & Cohen, 1979;Pedersen & Cohen, 1990a) or decamethonium and by their different labeling sensitivity to affinity reagents such as bromoacetylcholine, MBTA (Karlin et al, 1976;Damle & Karlin, 1978;Delegeane & McNamee, 1980;Ratnam et al, 1986) or lophotoxin (Culver, Fenical & Taylor, 1984). Also some antibodies differentially block the binding of oL bungarotoxin to one or the other a subunit (Watters & Maelicke, 1983;Gu, Silberstein & Hall, 1985;Whiting et al, 1985;Dowding & Hall, 1987).…”
Section: Contribution Of the Non A Subunits To The Ach Binding Sitesmentioning
confidence: 99%
“…They differ by their kinetics of binding and dissociation of a bungarotoxin (Weber & Changeux 1974a, b, c;Maelicke & Reich, 1976;Maelicke et al, 1977;Kang & Maelicke, 1980;Maelicke et al, 1989), by their affinities for the competitive antagonists d-tubocurarine (Neubig & Cohen, 1979;Pedersen & Cohen, 1990a) or decamethonium and by their different labeling sensitivity to affinity reagents such as bromoacetylcholine, MBTA (Karlin et al, 1976;Damle & Karlin, 1978;Delegeane & McNamee, 1980;Ratnam et al, 1986) or lophotoxin (Culver, Fenical & Taylor, 1984). Also some antibodies differentially block the binding of oL bungarotoxin to one or the other a subunit (Watters & Maelicke, 1983;Gu, Silberstein & Hall, 1985;Whiting et al, 1985;Dowding & Hall, 1987).…”
Section: Contribution Of the Non A Subunits To The Ach Binding Sitesmentioning
confidence: 99%
“…Although these sites may not be identical in structure, both are involved in channel opening. Even when one site is blocked by MBTA, ion flux could be induced by agonist binding to the second high-affinity site (Delegeane & McNamee 1980). ACh binding to these sites was shown to be weakly cooperative under desensitizing conditions (Fels et al 1982); models involving initially nonequivalent sites characterized by concave Scatchard plots (Prinz Maelicke 1983) and long-lived, variable affinity states (Chang et al 1984) have been proposed.…”
Section: Biochemistry Of Agonist and Antagonist Bindin9mentioning
confidence: 99%
“…Though only one of these sites can be affinity labeled after disulfide reduction, both sites appear capable of triggering permeability and desensitization response (Delegeane & McNamee, 1980). Perhaps the most careful recent measurements suggest that there are two ACh binding sites corresponding to the two toxin binding sites per monomer.…”
Section: Introductionmentioning
confidence: 99%